首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1776210

骨生長刺激植入裝置的全球市場 - 市場考察，競爭情形，市場預測(2032年)

Bone Growth Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日期: 2025年07月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球骨骼生長刺激器市場規模預計將在 2024 年達到 13.3703 億美元，到 2032 年將達到 20.2113 億美元，2025 年至 2032 年的複合年增長率為 5.34%。骨骼相關疾病、運動傷害和意外事故的發生率不斷上升，推動了全球對骨骼生長刺激器的需求。隨著越來越多的人遭受骨折、骨質疏鬆和創傷，骨骼生長刺激器有助於促進康復並改善療效，尤其是在老齡化人群和運動員群體中。此外，市場領導者加強產品開發力度，推動了非侵入性且更有效的骨骼生長刺激器的技術創新。這些進步，加上對更快、更可靠的骨骼癒合日益增長的需求，正在推動整個骨骼生長刺激器市場的發展。預計這些因素將在2025年至2032年的預測期內推動骨骼生長刺激器市場的發展。

骨骼生長刺激器市場動態

根據世界衛生組織 (WHO) 2023年的最新數據，全球約有5.28億人患有骨關節炎，1800萬人患有類風濕性關節炎。最常見的關節是膝關節，受影響人數達3.65億，其次是髖關節和手關節。這兩種疾病通常會損害骨骼的自然癒合能力，因此需要促進骨骼再生和修復的治療。骨骼生長刺激器利用電場、超音波和磁場來刺激骨骼癒合，正成為治療這些疾病的重要工具，進而推動全球整體骨骼生長刺激器市場的發展。

此外，交通事故的增加也是推動骨骼生長刺激器需求的主要因素。根據世界衛生組織 (WHO) 2023 年提供的最新數據，全球約有 2,000 萬至 5,000 萬人遭受非致命性傷害，其中許多是由道路交通事故造成的。道路交通事故 (RTA) 是造成創傷的主要原因，尤其是骨折和嚴重骨損傷，這可能會大幅推動骨骼生長刺激器的市場成長。這些設備可以加速癒合過程，尤其適用於傳統治療方法無法充分治療的複雜高風險骨折。此外，根據世界衛生組織 (WHO) 2024 年提供的最新數據，全球有超過 1500 萬人患有脊髓損傷。脊髓損傷通常會導致嚴重骨折和椎體損傷，可能損害骨癒合和脊椎穩定性。脊髓損傷患者通常需要手術，例如脊椎融合術，以穩定脊椎並促進復原。利用電、磁和超音波刺激的骨骼生長刺激器正越來越多地被用作輔助療法，以促進此類病例的骨再生和成功融合。

此外，全球越來越多的產品上市和獲批，進一步推動了整體骨骼生長刺激器市場的發展。例如，2024年4月，Xstim公司獲得了FDA對其Xstim™脊椎融合刺激器的批准。 Xstim脊椎融合裝置是一款可穿戴的非侵入式骨骼生長刺激器，可發出低能量訊號，促進脊椎融合術後患者的骨骼癒合。

然而，侵入式骨骼生長刺激器需要透過手術植入電極，這會帶來感染、出血和麻醉相關併發症等手術風險。產品召回的增多也可能阻礙骨骼生長刺激器市場未來的成長。

預計北美將主導整個骨骼生長刺激器市場。

在所有地區中，預計北美將在2024年佔據全球骨骼生長刺激器市場的最大佔有率。推動這一增長的關鍵因素包括骨骼相關疾病盛行率的上升、運動傷害和事故的增加、政府的支持以及積極參與策略發展的主要市場參與者的存在。預計這些因素將顯著提振該地區對骨骼生長刺激器的需求。

本報告研究並分析了全球骨骼生長刺激器市場，提供了市場規模和預測、過去三年的產品和技術發展、主要市場參與者以及可用機會等資訊。

Zimmer Biomet
Orthofix Medical Inc.
DJO, LLC
Bioventus
BTT Health GmbH
Stimulate Health
Kinex Medical Company, LLC.
Fintek Bio-Electric Inc.
Regen Lab SA
Arthrex, Inc.
Altis Biologics (Pty) Ltd.
TERUMO BCT, INC.
Medtronic
DePuy Synthes (Johnson & Johnson)
T-Biotechnology
D.r PRP USA LLC.
Ossatec 荷比盧三國 BV
ITO Co., Ltd.
Theragen
Xstim, Inc.

第9章 KOL的見解

第10章計劃方法

第11章關於DelveInsight

第12章免責聲明，諮詢方式

簡介目錄圖表

Product Code: DIMDCL0293

Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, and Ultrasonic Bone Growth Stimulators}, and Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), End-User (Hospitals, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of bone-related disorders, increase in sports injuries and accidents, and increase in product development activities by key market players across the globe.

The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032. The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

Bone Growth Stimulators Market Dynamics:

According to the latest data provided by the World Health Organization (WHO) (2023), approximately 528 million people globally were living with osteoarthritis and 18 million people were living with rheumatoid arthritis. The knee was the most commonly affected joint, with 365 million cases, followed by the hip and hand joints. In both conditions, the natural healing of bones is often impaired, necessitating interventions that promote bone regeneration and repair. Bone growth stimulators, which use electrical, ultrasound, or magnetic fields to stimulate bone healing, are becoming essential tools in managing these conditions thereby boosting the overall market of bone growth stimulators across the globe.

Moreover, the rise in road traffic accidents is another major factor leading to the rising demand for bone growth stimulators. According to the recent data provided by the World Health Organization (WHO) (2023), approximately 20 to 50 million people suffered non-fatal injuries, with many incurring a disability in road traffic injuries. Road traffic accidents (RTAs) are a major contributor to traumatic injuries, particularly fractures and severe bone damage, which can significantly boost the market for bone growth stimulators. These devices accelerate the healing process, especially in complex or high-risk fractures where traditional healing methods may be insufficient.

Additionally, as per the recent data provided by the World Health Organization (2024), globally, over 15 million people were living with spinal cord injury. Spinal cord injuries often result in severe fractures and vertebral damage, which can impair bone healing and spinal stability. Patients with spinal cord injuries frequently require surgeries, such as spinal fusions, to stabilize the spine and facilitate recovery. Bone growth stimulators, which use electrical, magnetic, or ultrasound stimulation, are increasingly used as an adjunct therapy to enhance bone regeneration and promote successful fusion in these cases.

Moreover, the increase in product launches and approval across the globe is further propelling the overall market of bone growth stimulators. For instance, in April 2024, Xstim, Inc., received FDA approval for Xstim(TM) Spine Fusion Stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.

However, invasive bone growth stimulators require surgical implantation of electrodes, which introduces risks associated with surgery, such as infection, bleeding, and complications related to anesthesia and the increased number of product recalls may hinder the future market of bone growth stimulators market growth.

Bone Growth Stimulators Market Segment Analysis:

In the product segment of the bone growth stimulators market, the Capacitive Coupling (CC) devices category is expected to hold the largest share in the year 2024. Capacitive coupling devices are significantly boosting the overall market of bone growth stimulators due to their non-invasive nature and proven effectiveness in enhancing bone healing. These devices work by delivering a low-level electrical signal through capacitive plates placed on the skin, creating an electric field that stimulates bone cells to accelerate the healing process. Unlike invasive procedures, capacitive coupling devices offer a safer and more comfortable option for patients recovering from fractures, spinal fusions, or non-union bones. Their ability to be used in home settings and their portability increase patient compliance and accessibility, making them a favored option in the orthopedic and trauma care markets. Additionally, capacitive coupling devices are particularly beneficial for patients who cannot undergo surgery or for whom conventional treatments have failed. As awareness of these benefits grows, alongside advancements in capacitive coupling technology, the demand for bone growth stimulators has seen a marked increase, further expanding the market. Moreover, the cost-effectiveness and ease of use of capacitive coupling devices make them an attractive option for healthcare providers, contributing to their growing adoption in both hospital and outpatient settings.

Several innovative CC-based products illustrate the impact of this technology on the market. For instance, the Xstim(TM) Spine Fusion Stimulator by Xstim, Inc., is a non-invasive device designed to promote bone growth following spinal fusion surgery. It features an intuitive interface and a built-in capacitive coupling mechanism to deliver consistent, effective therapy. Another example is Theragen's ActaStim(R) System, which offers a sleek, wearable solution combining CC-based electrical stimulation with real-time data collection for enhanced compliance and personalized care. These devices are gaining traction not only in the United States but also in global markets, driven by the increasing incidence of spinal disorders, orthopedic trauma, and demand for alternatives to repeat surgeries. As clinical evidence continues to support their efficacy and manufacturers integrate user-friendly features and digital connectivity, capacitive coupling devices are playing a pivotal role in the growth of the bone growth stimulator market.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global bone growth stimulators market during the forecast period.

North America is expected to dominate the overall bone growth stimulators market:

Among all regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. Key drivers fueling this growth include the rising prevalence of bone-related disorders, an increase in sports-related injuries and accidents, supportive government initiatives, and the strong presence of key market players actively engaged in strategic developments. Collectively, these factors are anticipated to significantly boost the demand for bone growth stimulators across the region.

According to recent data from the Centers for Disease Control and Prevention (CDC, 2024), the age-adjusted prevalence of diagnosed arthritis among U.S. adults aged 18 and older was 18.9% in 2022. Women were more likely to be affected (21.5%) than men (16.1%). The prevalence of arthritis increases with age, rising from 3.6% among adults aged 18-34 to 53.9% in those aged 75 and older. As arthritis progresses, it often results in joint deterioration, bone erosion, and non-healing fracture conditions that require advanced interventions to stimulate bone regeneration. Bone growth stimulators, which utilize electrical or ultrasound stimulation, play a critical role in accelerating bone healing and alleviating pain. Their use in managing arthritis-related complications is therefore contributing to the expansion of the market in North America.

Furthermore, as per CDC data (2023), there were approximately 25.5 million emergency department visits in the U.S. due to unintentional injuries. The growing number of injuries increases the need for effective bone healing technologies. Bone growth stimulators offer improved recovery times and reduced complications, making them a valuable solution for a broad range of injury-related cases.

In addition, the presence of leading medical device manufacturers such as Arthrex Inc., Stryker Corporation, and Medtronic along with their strategic initiatives focused on product innovation and expansion further drives market growth in the region. These companies are actively developing advanced bone growth stimulators to address a variety of bone-related conditions, strengthening the market landscape and enhancing access to innovative solutions.

In summary, the combination of a high disease and injury burden, robust healthcare infrastructure, active government initiatives, and the strong presence of leading players positions North America as a dominant force in the global bone growth stimulators market during the forecast period.

Bone Growth Stimulators Market Key Players:

Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

Recent Developmental Activities in the Bone Growth Stimulators Market:

In August 2022, Theragen, a biologics company, announced that it received the U.S. Patent for its ActaStim-S spine fusion bone growth stimulator system.
In May 2022, Orthofix US LLC. received FDA approval for the AccelStim bone growth stimulator. The AccelStim bone growth stimulator delivers a high-frequency sound wave (ultrasound signal) to encourage bone growth and help heal broken bones (bone fractures).

Key takeaways from the bone growth stimulators market report study:

Market size analysis for current bone growth stimulators size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the bone growth stimulators market.
Various opportunities available for the other competitors in the bone growth stimulators market space.
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current bone growth stimulators market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for bone growth stimulators market growth in the coming future?

Target audience who can benefit from this bone growth stimulators market report study:

Bone growth stimulator product providers
Research organizations and consulting companies
Bone growth stimulators-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in bone growth stimulators
Various end-users who want to know more about the bone growth stimulators market and the latest technological developments in the bone growth stimulators market.

Frequently Asked Questions for the Bone Growth Stimulators Market:

1. What are bone growth stimulators?

A bone stimulator is a device that generates an electric current used to promote bone growth. It uses ultrasonic or pulsed electromagnetic waves. Bone stimulators are either external or surgically implanted into the area of the affected bone.

2. What is the market for bone growth stimulators?

The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032.

3. What are the drivers for the bone growth stimulators market?

The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

4. Who are the key players operating in the bone growth stimulators market?

Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

5. Which region has the highest share in the bone growth stimulators market?

Among all the regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. The key driving factors of the bone growth stimulators market are the increasing prevalence of bone-related disorders, an increase in sports-related injuries and accidents, increased government initiatives, and the presence of key players engaged in strategic activities in the region. Collectively, these factors are expected to boost the overall market of bone growth stimulators across the region.

1. Bone Growth Stimulators Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Bone Growth Stimulators Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Bone Growth Stimulators Market Key Factors Analysis

5.1. Bone Growth Stimulators Market Drivers
- 5.1.1. The rising incidence of bone-related disorders
- 5.1.2. Increase in sports injuries and accidents
- 5.1.3. Increase in product development activities by key market players across the globe.
5.2. Bone Growth Stimulators Market Restraints and Challenges
- 5.2.1. Invasive bone growth stimulators require surgical implantation which introduces risks such as infection, bleeding, and complications
- 5.2.2. The increased number of product recalls
5.3. Bone Growth Stimulators Market Opportunities
- 5.3.1. Ongoing technological advancements such as enhanced electrical stimulation devices and ultrasound-based systems

6. Bone Growth Stimulators Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Bone Growth Stimulators Market Assessment

7.1. By Product
- 7.1.1. Bone Growth Stimulation Devices
  - 7.1.1.1. Non-invasive Bone Growth Stimulators
  - 7.1.1.1.1. Combined Magnetic Field (CMF) Devices
  - 7.1.1.1.2. Capacitive Coupling (CC) Devices
  - 7.1.1.1.3. Pulsed Electromagnetic Field (PEMF) Devices
  - 7.1.1.1.4. Ultrasonic Bone Growth Stimulators
  - 7.1.1.2. Invasive Bone Growth Stimulators
- 7.1.2. Bone Morphogenetic Proteins (BMP)
- 7.1.3. Platelet-rich plasma (PRP)
7.2. By Application
- 7.2.1. Spinal Fusion Surgeries
- 7.2.2. Delayed Union & Nonunion Bone Fractures
- 7.2.3. Oral & Maxillofacial Surgeries
- 7.2.4. Others
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Homecare
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.1.2. Canada Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.1.3. Mexico Bone Growth Stimulators Market Size in USD million (2022-2032)
- 7.4.2. Europe
  - 7.4.2.1. France Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.2.2. Germany Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.2.3. United Kingdom Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.2.4. Italy Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.2.5. Spain Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.2.6. Rest of Europe Bone Growth Stimulators Market Size in USD million (2022-2032)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.3.2. Japan Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.3.3. India Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.3.4. Australia Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.3.5. South Korea Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.3.6. Rest of Asia-Pacific Bone Growth Stimulators Market Size in USD million (2022-2032)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.4.2. Africa Bone Growth Stimulators Market Size in USD million (2022-2032)
  - 7.4.4.3. South America Bone Growth Stimulators Market Size in USD million (2022-2032)

8. Bone Growth Stimulators Market Company and Product Profiles

8.1. Zimmer Biomet
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Orthofix Medical Inc.
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. DJO, LLC
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Bioventus
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. BTT Health GmbH
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Stimulate Health
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Kinex Medical Company, LLC.
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Fintek Bio-Electric Inc.
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Regen Lab SA
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Arthrex, Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Altis Biologics (Pty) Ltd.
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. TERUMO BCT, INC.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Medtronic
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. DePuy Synthes (Johnson & Johnson)
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. T-Biotechnology
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. D.r PRP USA LLC.
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Ossatec Benelux BV
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. ITO Co., Ltd.
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Theragen
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Xstim, Inc.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy